RxDoctor Payments Data

Brealon Lirette

Psychiatric/Mental Health · Marrero, LANPI 1710400833

Payments from drug & device makers

$1,598in general payments, 2019–2025

Across 88 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$360
  • Teva Pharmaceuticals USA, Inc.$234
  • Otsuka America Pharmaceutical, Inc.$211
  • Johnson & Johnson$197
  • Indivior Inc.$174
  • Neurocrine Biosciences, Inc.$139
  • plus $283 from 5 others

What the payments were for

  • Food & beverage$1,55197%
  • Education$473%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,598 in reported general payments places this provider in the 55th percentile of 615 psychiatric/mental health providers in Louisiana.

See all psychiatric/mental health providers in Louisiana

Medicare billing

Part B allowed, 2024
$75,960
Medicare patients
216
Services billed
784

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate87$269,791
PerserisRisperidone52$153,195
Abilify MaintenaAripiprazole33$98,349
VraylarCariprazine Hcl13$19,440
Aripiprazole88$3,024
Paliperidone ErPaliperidone16$2,272
Divalproex Sodium120$2,218
Haloperidol68$2,215
Olanzapine75$2,069
Clozapine19$1,700
Divalproex Sodium ErDivalproex Sodium55$1,573
Quetiapine Fumarate90$1,217
Benztropine Mesylate89$1,020
Oxcarbazepine23$1,015
Hydroxyzine Pamoate44$902

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$197$269,79187 claims
Indivior Inc.Perseris$174$153,19552 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$211$98,34933 claims
AbbVieVraylar$79$19,44013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 615 psychiatric/mental health providers in Louisiana.

Other psychiatric/mental health in Marrero

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →